Related News
China’s vaccine enters clinical trial
Print Edition
AN Ebola vaccine developed by China has been approved to enter the human test stage, the People’s Liberation Army’s General Logistics Department announced yesterday.
The restructured vaccine, developed by the Academy of Military Medical Sciences, is based on the 2014 mutant gene type and especially targets the strain plaguing west Africa.
The freeze-dried powder form of the vaccine will keep it stable for at least two weeks in temperatures of up to 37 degrees Celsius. This will make it suitable for the tropical west African region, according to a review by 17 experts.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
